Global Fibromyalgia Treatment Drug Market Insights, Forecast to 2028

Global Fibromyalgia Treatment Drug Market Insights, Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cymbalta (Duloxetine)
1.2.3 Savella (Milnacipran)
1.2.4 Lyrica (Pregabalin)
1.2.5 Pancuronium
1.2.6 Others
1.3 Market by Application
1.3.1 Global Fibromyalgia Treatment Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fibromyalgia Treatment Drug Market Perspective (2017-2028)
2.2 Fibromyalgia Treatment Drug Growth Trends by Region
2.2.1 Fibromyalgia Treatment Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fibromyalgia Treatment Drug Historic Market Size by Region (2017-2022)
2.2.3 Fibromyalgia Treatment Drug Forecasted Market Size by Region (2023-2028)
2.3 Fibromyalgia Treatment Drug Market Dynamics
2.3.1 Fibromyalgia Treatment Drug Industry Trends
2.3.2 Fibromyalgia Treatment Drug Market Drivers
2.3.3 Fibromyalgia Treatment Drug Market Challenges
2.3.4 Fibromyalgia Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fibromyalgia Treatment Drug Players by Revenue
3.1.1 Global Top Fibromyalgia Treatment Drug Players by Revenue (2017-2022)
3.1.2 Global Fibromyalgia Treatment Drug Revenue Market Share by Players (2017-2022)
3.2 Global Fibromyalgia Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fibromyalgia Treatment Drug Revenue
3.4 Global Fibromyalgia Treatment Drug Market Concentration Ratio
3.4.1 Global Fibromyalgia Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Treatment Drug Revenue in 2021
3.5 Fibromyalgia Treatment Drug Key Players Head office and Area Served
3.6 Key Players Fibromyalgia Treatment Drug Product Solution and Service
3.7 Date of Enter into Fibromyalgia Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fibromyalgia Treatment Drug Breakdown Data by Type
4.1 Global Fibromyalgia Treatment Drug Historic Market Size by Type (2017-2022)
4.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2023-2028)
5 Fibromyalgia Treatment Drug Breakdown Data by Application
5.1 Global Fibromyalgia Treatment Drug Historic Market Size by Application (2017-2022)
5.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fibromyalgia Treatment Drug Market Size (2017-2028)
6.2 North America Fibromyalgia Treatment Drug Market Size by Type
6.2.1 North America Fibromyalgia Treatment Drug Market Size by Type (2017-2022)
6.2.2 North America Fibromyalgia Treatment Drug Market Size by Type (2023-2028)
6.2.3 North America Fibromyalgia Treatment Drug Market Share by Type (2017-2028)
6.3 North America Fibromyalgia Treatment Drug Market Size by Application
6.3.1 North America Fibromyalgia Treatment Drug Market Size by Application (2017-2022)
6.3.2 North America Fibromyalgia Treatment Drug Market Size by Application (2023-2028)
6.3.3 North America Fibromyalgia Treatment Drug Market Share by Application (2017-2028)
6.4 North America Fibromyalgia Treatment Drug Market Size by Country
6.4.1 North America Fibromyalgia Treatment Drug Market Size by Country (2017-2022)
6.4.2 North America Fibromyalgia Treatment Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Fibromyalgia Treatment Drug Market Size (2017-2028)
7.2 Europe Fibromyalgia Treatment Drug Market Size by Type
7.2.1 Europe Fibromyalgia Treatment Drug Market Size by Type (2017-2022)
7.2.2 Europe Fibromyalgia Treatment Drug Market Size by Type (2023-2028)
7.2.3 Europe Fibromyalgia Treatment Drug Market Share by Type (2017-2028)
7.3 Europe Fibromyalgia Treatment Drug Market Size by Application
7.3.1 Europe Fibromyalgia Treatment Drug Market Size by Application (2017-2022)
7.3.2 Europe Fibromyalgia Treatment Drug Market Size by Application (2023-2028)
7.3.3 Europe Fibromyalgia Treatment Drug Market Share by Application (2017-2028)
7.4 Europe Fibromyalgia Treatment Drug Market Size by Country
7.4.1 Europe Fibromyalgia Treatment Drug Market Size by Country (2017-2022)
7.4.2 Europe Fibromyalgia Treatment Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size (2017-2028)
8.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type
8.2.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fibromyalgia Treatment Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application
8.3.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fibromyalgia Treatment Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region
8.4.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fibromyalgia Treatment Drug Market Size (2017-2028)
9.2 Latin America Fibromyalgia Treatment Drug Market Size by Type
9.2.1 Latin America Fibromyalgia Treatment Drug Market Size by Type (2017-2022)
9.2.2 Latin America Fibromyalgia Treatment Drug Market Size by Type (2023-2028)
9.2.3 Latin America Fibromyalgia Treatment Drug Market Share by Type (2017-2028)
9.3 Latin America Fibromyalgia Treatment Drug Market Size by Application
9.3.1 Latin America Fibromyalgia Treatment Drug Market Size by Application (2017-2022)
9.3.2 Latin America Fibromyalgia Treatment Drug Market Size by Application (2023-2028)
9.3.3 Latin America Fibromyalgia Treatment Drug Market Share by Application (2017-2028)
9.4 Latin America Fibromyalgia Treatment Drug Market Size by Country
9.4.1 Latin America Fibromyalgia Treatment Drug Market Size by Country (2017-2022)
9.4.2 Latin America Fibromyalgia Treatment Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size (2017-2028)
10.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type
10.2.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fibromyalgia Treatment Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application
10.3.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fibromyalgia Treatment Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country
10.4.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fibromyalgia Treatment Drug Introduction
11.1.4 Pfizer Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Fibromyalgia Treatment Drug Introduction
11.2.4 Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.2.5 Eli Lilly Recent Developments
11.3 Actavis Generics
11.3.1 Actavis Generics Company Details
11.3.2 Actavis Generics Business Overview
11.3.3 Actavis Generics Fibromyalgia Treatment Drug Introduction
11.3.4 Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.3.5 Actavis Generics Recent Developments
11.4 Merck Sharp and Dohme
11.4.1 Merck Sharp and Dohme Company Details
11.4.2 Merck Sharp and Dohme Business Overview
11.4.3 Merck Sharp and Dohme Fibromyalgia Treatment Drug Introduction
11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.4.5 Merck Sharp and Dohme Recent Developments
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction
11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.5.5 Daiichi Sankyo Recent Developments
11.6 Innovative Med Concepts
11.6.1 Innovative Med Concepts Company Details
11.6.2 Innovative Med Concepts Business Overview
11.6.3 Innovative Med Concepts Fibromyalgia Treatment Drug Introduction
11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.6.5 Innovative Med Concepts Recent Developments
11.7 Meda
11.7.1 Meda Company Details
11.7.2 Meda Business Overview
11.7.3 Meda Fibromyalgia Treatment Drug Introduction
11.7.4 Meda Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.7.5 Meda Recent Developments
11.8 Meiji Seika
11.8.1 Meiji Seika Company Details
11.8.2 Meiji Seika Business Overview
11.8.3 Meiji Seika Fibromyalgia Treatment Drug Introduction
11.8.4 Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.8.5 Meiji Seika Recent Developments
11.9 Switch Biotech
11.9.1 Switch Biotech Company Details
11.9.2 Switch Biotech Business Overview
11.9.3 Switch Biotech Fibromyalgia Treatment Drug Introduction
11.9.4 Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.9.5 Switch Biotech Recent Developments
11.10 Theravance
11.10.1 Theravance Company Details
11.10.2 Theravance Business Overview
11.10.3 Theravance Fibromyalgia Treatment Drug Introduction
11.10.4 Theravance Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.10.5 Theravance Recent Developments
11.11 Zynerba Pharmaceuticals
11.11.1 Zynerba Pharmaceuticals Company Details
11.11.2 Zynerba Pharmaceuticals Business Overview
11.11.3 Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Introduction
11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.11.5 Zynerba Pharmaceuticals Recent Developments
11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Introduction
11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction
11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.13.5 Daiichi Sankyo Recent Developments
11.14 Forest Pharmaceuticals, Inc.
11.14.1 Forest Pharmaceuticals, Inc. Company Details
11.14.2 Forest Pharmaceuticals, Inc. Business Overview
11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Introduction
11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.14.5 Forest Pharmaceuticals, Inc. Recent Developments
11.15 Boehringer Ingelheim GmbH
11.15.1 Boehringer Ingelheim GmbH Company Details
11.15.2 Boehringer Ingelheim GmbH Business Overview
11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Introduction
11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.15.5 Boehringer Ingelheim GmbH Recent Developments
11.16 Pierre Fabre Medicament
11.16.1 Pierre Fabre Medicament Company Details
11.16.2 Pierre Fabre Medicament Business Overview
11.16.3 Pierre Fabre Medicament Fibromyalgia Treatment Drug Introduction
11.16.4 Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2017-2022)
11.16.5 Pierre Fabre Medicament Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Cymbalta (Duloxetine)
Table 3. Key Players of Savella (Milnacipran)
Table 4. Key Players of Lyrica (Pregabalin)
Table 5. Key Players of Pancuronium
Table 6. Key Players of Others
Table 7. Global Fibromyalgia Treatment Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Fibromyalgia Treatment Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Fibromyalgia Treatment Drug Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Fibromyalgia Treatment Drug Market Share by Region (2017-2022)
Table 11. Global Fibromyalgia Treatment Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Fibromyalgia Treatment Drug Market Share by Region (2023-2028)
Table 13. Fibromyalgia Treatment Drug Market Trends
Table 14. Fibromyalgia Treatment Drug Market Drivers
Table 15. Fibromyalgia Treatment Drug Market Challenges
Table 16. Fibromyalgia Treatment Drug Market Restraints
Table 17. Global Fibromyalgia Treatment Drug Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Fibromyalgia Treatment Drug Revenue Share by Players (2017-2022)
Table 19. Global Top Fibromyalgia Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment Drug as of 2021)
Table 20. Ranking of Global Top Fibromyalgia Treatment Drug Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Fibromyalgia Treatment Drug Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Fibromyalgia Treatment Drug Product Solution and Service
Table 24. Date of Enter into Fibromyalgia Treatment Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2017-2022)
Table 28. Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2023-2028)
Table 30. Global Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Fibromyalgia Treatment Drug Revenue Share by Application (2017-2022)
Table 32. Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Fibromyalgia Treatment Drug Revenue Share by Application (2023-2028)
Table 34. North America Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Fibromyalgia Treatment Drug Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Fibromyalgia Treatment Drug Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Fibromyalgia Treatment Drug Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Fibromyalgia Treatment Drug Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Fibromyalgia Treatment Drug Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Fibromyalgia Treatment Drug Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Fibromyalgia Treatment Drug Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Fibromyalgia Treatment Drug Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Fibromyalgia Treatment Drug Market Size by Country (2023-2028) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Fibromyalgia Treatment Drug Product
Table 67. Pfizer Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Eli Lilly Company Details
Table 70. Eli Lilly Business Overview
Table 71. Eli Lilly Fibromyalgia Treatment Drug Product
Table 72. Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 73. Eli Lilly Recent Developments
Table 74. Actavis Generics Company Details
Table 75. Actavis Generics Business Overview
Table 76. Actavis Generics Fibromyalgia Treatment Drug Product
Table 77. Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 78. Actavis Generics Recent Developments
Table 79. Merck Sharp and Dohme Company Details
Table 80. Merck Sharp and Dohme Business Overview
Table 81. Merck Sharp and Dohme Fibromyalgia Treatment Drug Product
Table 82. Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 83. Merck Sharp and Dohme Recent Developments
Table 84. Daiichi Sankyo Company Details
Table 85. Daiichi Sankyo Business Overview
Table 86. Daiichi Sankyo Fibromyalgia Treatment Drug Product
Table 87. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 88. Daiichi Sankyo Recent Developments
Table 89. Innovative Med Concepts Company Details
Table 90. Innovative Med Concepts Business Overview
Table 91. Innovative Med Concepts Fibromyalgia Treatment Drug Product
Table 92. Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 93. Innovative Med Concepts Recent Developments
Table 94. Meda Company Details
Table 95. Meda Business Overview
Table 96. Meda Fibromyalgia Treatment Drug Product
Table 97. Meda Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 98. Meda Recent Developments
Table 99. Meiji Seika Company Details
Table 100. Meiji Seika Business Overview
Table 101. Meiji Seika Fibromyalgia Treatment Drug Product
Table 102. Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 103. Meiji Seika Recent Developments
Table 104. Switch Biotech Company Details
Table 105. Switch Biotech Business Overview
Table 106. Switch Biotech Fibromyalgia Treatment Drug Product
Table 107. Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 108. Switch Biotech Recent Developments
Table 109. Theravance Company Details
Table 110. Theravance Business Overview
Table 111. Theravance Fibromyalgia Treatment Drug Product
Table 112. Theravance Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 113. Theravance Recent Developments
Table 114. Zynerba Pharmaceuticals Company Details
Table 115. Zynerba Pharmaceuticals Business Overview
Table 116. Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Product
Table 117. Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 118. Zynerba Pharmaceuticals Recent Developments
Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
Table 121. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Product
Table 122. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 123. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments
Table 124. Daiichi Sankyo Company Details
Table 125. Daiichi Sankyo Business Overview
Table 126. Daiichi Sankyo Fibromyalgia Treatment Drug Product
Table 127. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 128. Daiichi Sankyo Recent Developments
Table 129. Forest Pharmaceuticals, Inc. Company Details
Table 130. Forest Pharmaceuticals, Inc. Business Overview
Table 131. Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Product
Table 132. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 133. Forest Pharmaceuticals, Inc. Recent Developments
Table 134. Boehringer Ingelheim GmbH Company Details
Table 135. Boehringer Ingelheim GmbH Business Overview
Table 136. Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Product
Table 137. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 138. Boehringer Ingelheim GmbH Recent Developments
Table 139. Pierre Fabre Medicament Company Details
Table 140. Pierre Fabre Medicament Business Overview
Table 141. Pierre Fabre Medicament Fibromyalgia Treatment Drug Product
Table 142. Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2017-2022) & (US$ Million)
Table 143. Pierre Fabre Medicament Recent Developments
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fibromyalgia Treatment Drug Market Share by Type: 2021 VS 2028
Figure 2. Cymbalta (Duloxetine) Features
Figure 3. Savella (Milnacipran) Features
Figure 4. Lyrica (Pregabalin) Features
Figure 5. Pancuronium Features
Figure 6. Others Features
Figure 7. Global Fibromyalgia Treatment Drug Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Household Case Studies
Figure 11. Others Case Studies
Figure 12. Fibromyalgia Treatment Drug Report Years Considered
Figure 13. Global Fibromyalgia Treatment Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Fibromyalgia Treatment Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Fibromyalgia Treatment Drug Market Share by Region: 2021 VS 2028
Figure 16. Global Fibromyalgia Treatment Drug Market Share by Players in 2021
Figure 17. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment Drug as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Fibromyalgia Treatment Drug Revenue in 2021
Figure 19. North America Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 21. North America Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 22. North America Fibromyalgia Treatment Drug Market Size Share by Country (2017-2028)
Figure 23. United States Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 27. Europe Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 28. Europe Fibromyalgia Treatment Drug Market Size Share by Country (2017-2028)
Figure 29. Germany Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Fibromyalgia Treatment Drug Market Size Share by Region (2017-2028)
Figure 39. China Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Fibromyalgia Treatment Drug Market Size Share by Country (2017-2028)
Figure 49. Mexico Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Fibromyalgia Treatment Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Fibromyalgia Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Fibromyalgia Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Fibromyalgia Treatment Drug Market Size Share by Country (2017-2028)
Figure 55. Turkey Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Fibromyalgia Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 59. Eli Lilly Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 60. Actavis Generics Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 61. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 62. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 63. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 64. Meda Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 65. Meiji Seika Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 66. Switch Biotech Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 67. Theravance Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 68. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-2022)
Figure 69. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2017-

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs